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Importance of 3 h when dialyzing
daily
To the Editor: Brunelli et al.,1 by using a rigorous statistical
analysis, conﬁrm previous information on the association
between short dialysis time and increased mortality. Recent
studies could shed light on the mechanistic reasons for this
association. In a prospective, non-randomized study of
77 dialysis patients, subjects who underwent 3 h daily dialysis
(3 h, six times weekly) had a signiﬁcant decrease in left
ventricular mass, phosphorus and inﬂammation compared
with those who underwent conventional dialysis.2,3 Thus, as
Brunelli et al. rightly predict, a longer dialysis time is
beneﬁcial in improving the markers associated with increased
mortality. Unfortunately, many nephrologists and the dialysis
industry as a whole are still using the Kt/V urea kinetics over
dialysis time in determining dialysis prescriptions.
Even the current NIH-sponsored daily dialysis trial is
using the urea kinetics-based approach for treatment
times in the in-center daily dialysis arm. It is predicted
that they will fall below that 3-h treatment time mark that
we have advocated.3 Shorter dialysis times (less than 3 h),
even when prescribed 6 days a week, do not adequately
control serum phosphorus, an important marker of dialysis
mortality.3
Lastly, one disturbing ﬁnding in the study is the percentage
(61.5%) of patients initiating dialysis through a catheter. In
addition to increased infections, catheters are independently
associated with increased inﬂammation even when they are
not infected.4
Thus, two simple therapeutic maneuvers—increased dia-
lysis time and frequency to improve serum phosphorus
control and avoiding dialysis catheters—can improve survival.
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The Authors Reply: As Drs Ayus and Achinger rightfully
note,1 longer dialytic session length is associated with
improved patient survival even when measures of urea
kinetics conform to the current standards of care. We agree
that this effect may be mediated in part through improved
phosphate homeostasis. Consequently we estimated the
marginal structural hazards ratio for death by comparing
session lengths o240min with those X240min among
subgroups of patients with baseline serum phosphate p5.5
and 45.5mg/dl: 1.42 (1.22–1.65) and 1.38 (1.03–1.85),
respectively. That the estimates were similar in both serum
phosphorus subgroups may indicate that derangements in
phosphate metabolism exceed those reﬂected by serum
phosphate concentrations, such as consequent elevations in
serum FGF-23, which are themselves associated with
increased mortality.2
Amelioration of left ventricular hypertrophy may underlie
the association between dialytic session length and survival,
and may itself derive from more gradual ultraﬁltration rates
and consistent attainment of dry weight enabled by longer
dialysis. We believe that the ‘adequacy’ of ultraﬁltration
warrants further study.
We agree that our ﬁndings are consistent with the notion
that more dialysis is better, and this may bear relevance for
other (for example, short daily) dialytic paradigms. However,
we urge caution with extrapolation beyond the context of
thrice-weekly dialysis settings, given the absence of otherwise
treated patients in the cohort we examined.
Finally, we echo the authors’ concern that catheter use is
epidemic, noting that more contemporary data from United
States Renal Data Service indicate a catheter prevalence of
83.5% among incident hemodialysis patients.3
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In defense of the Stewart
approach to acid–base analysis
To the Editor: Adrogue describes the physicochemical
approach as ‘unduly complex.’1
In reference to the complexity of making the calculations,
the difﬁculty arises from the need to enter all the relevant data
for a Stewart type analysis manually into a calculator, whereas
our point-of-care-machines automatically give us all the
calculations on the basis of bicarbonate approach. The van
Slyke formula2 the machine software uses to calculate BE
is hardly less complex than those needed for the physio-
chemical approach. It ought to be easy to integrate Stewart’s
formulae into the machine software. This has, to our
knowledge, only been carried out at one hospital up to
now: Hawke’s Bay Hospital in New Zealand, thanks to the
late Peter Lloyd.3
As for the complexity of the results themselves, such is the
real situation in a typical intensive care patient. We do not
doubt that Adrogue’s cases can be analyzed by the bicarbonate
approach, if the anion gap is corrected for albumin
concentration. The author describes this correctly: ‘the
plasma anion gap must be adjusted by subtracting or adding
2.5mEq/l for each 1 g/dl of plasma albumin below or above
the average normal value of 4.5 g/dl’. In other words, they
calculate the anionic charge carried by albumin, implicitly
recognizing the weak acid nature of albumin. Why then do
they declare ‘hypoalbuminemic alkalosis, a condition of
questionable existence’? Albumin’s negative charge varies
with pH, which is what characterizes a weak acid? This has
been known for almost a century, see the work by the Nestor
of acid–base physiology, Donald Van Slyke.4
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Figure 1 |Points representing experimental results from the
tables.K, CO2 titration of albumin.J, CO2 titration of albumin.
&, Electrometric titration of albumin.  , CO2 titration of globulin.
þ , Electrometric titration of globulin.B, Electrometric titration of
globulin. The linear curves indicate the mean values of results
from the different albumin and globulin preparations, and the
estimated values for a mixture of 1.6 parts of albumin and 1.0 part
of globulin, such as is approximated in normal human serum.
Donald Van Slyke, Studies of Gas and Electrolyte Equilibria in
Blood, 1928 (4, p 774), with permission from the Journal of
Biological Chemistry.
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